|
|
|
|
LEADER |
00000cam a22000007 4500 |
001 |
SCIDIR_ocn557779871 |
003 |
OCoLC |
005 |
20231117032909.0 |
006 |
m o d |
007 |
cr bn||||||abp |
007 |
cr bn||||||ada |
008 |
100317s1980 xx o 100 0 eng d |
040 |
|
|
|a OCLCE
|b eng
|e pn
|c OCLCE
|d OCLCQ
|d OCLCO
|d OCLCQ
|d UIU
|d OCLCF
|d N$T
|d EBLCP
|d DEBSZ
|d OCL
|d OCLCQ
|d YDXCP
|d MERUC
|d OCLCQ
|d COM
|d OCLCO
|d OCLCQ
|d OCLCO
|
066 |
|
|
|c (S
|
019 |
|
|
|a 632080998
|a 895430187
|a 948687816
|a 974618449
|a 1153460059
|
020 |
|
|
|a 9781483145266
|q (electronic bk.)
|
020 |
|
|
|a 1483145263
|q (electronic bk.)
|
020 |
|
|
|z 0080254888
|
020 |
|
|
|z 9780080254883
|
035 |
|
|
|a (OCoLC)557779871
|z (OCoLC)632080998
|z (OCoLC)895430187
|z (OCoLC)948687816
|z (OCoLC)974618449
|z (OCoLC)1153460059
|
042 |
|
|
|a dlr
|
050 |
|
4 |
|a QP951.E5
|b I56 1979
|
072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
082 |
0 |
4 |
|a 615/.782
|
245 |
0 |
0 |
|a Endogenous and exogenous opiate agonists and antagonists.
|
260 |
|
|
|b Pergamon,
|c 1980.
|
300 |
|
|
|a 1 online resource
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
506 |
|
|
|3 Use copy
|f Restrictions unspecified
|5 MiAaHDL
|2 star
|
533 |
|
|
|a Electronic reproduction.
|b [Place of publication not identified] :
|c HathiTrust Digital Library,
|d 2010.
|5 MiAaHDL
|
538 |
|
|
|a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002.
|u http://purl.oclc.org/DLF/benchrepro0212
|5 MiAaHDL
|
583 |
1 |
|
|a digitized
|c 2010
|h HathiTrust Digital Library
|l committed to preserve
|5 MiAaHDL
|2 pda
|
588 |
0 |
|
|a Print version record.
|
505 |
8 |
|
|6 880-01
|a Chapter 10. INTERACTION OF A MODEL OPIATE ANIONIC RECEPTOR SITE WITH N-SUBSTITUENTS OF RIGID OPIATES: PCILO ENERGY CALCULATIONSSummary; Method and Procedure; Results and Discussion; Conclusions; Literature Cited; Chapter 11. EFFECTS OF MONOVALENT CATIONS ON CEREBROSIDE SULFATE BINDING TO OPIATE AGONISTS AND ANTAGONISTS; Summary; Methods; Results and Discussion; Acknowdgement; References; Chapter 12. OPIATE BINDING AND CEREBROSIDE SULFATES IN BRAIN AND LUNG OF DEVELOPING CHICK; Summary; Methods; Results and Discussion; REFERENCES.
|
505 |
8 |
|
|a Chapter 13. OPIATE RECEPTOR BINDING STUDIES INFLUENCE OF A REVERSIBLE SULFHYDRYL REAGENTSummary; Materials and Methods; Results and Discussion; Acknowledgements; References; Chapter 14. ASCORBATE DESTRUCTION OF OPIOID STEREOSPECIFIC BINDING; EVIDENCE FOR RECEPTOR REGULATION BY MEMBRANE LIPID; Summary; Acknowledgements; References; Chapter 15. THE STUDY OF ENKEPHALIN-RECEPTOR INTERACTION USING ISOSTERICALLY MODIFIED ANALOGUES; Summary; Methods; Results; Discussion; Acknowledgements; References; Addendum; Chapter 16. SEASONAL VARIATION IN THE APPARENT NUMBER OF 3H-NALOXONE BINDING SITES.
|
520 |
|
|
|a Endogenous and Exogenous Opiate Agonists and Antagonists documents the proceedings of the International Narcotic Research Club Conference, held in North Falmouth, Massachusetts, USA, on 11-15 June 1979. The volume begins with a discussion of the programs of the World Health Organization, with an emphasis on the components of its drug dependence program. The 139 papers discussed at the conference are then presented. These papers are organized into 10 parts. The papers in Part I examine structure-activity relationships. Part II contains studies on receptor binding while Part III deals with the l.
|
650 |
|
0 |
|a Endorphins
|v Congresses.
|
650 |
|
0 |
|a Endorphin antagonists
|v Congresses.
|
650 |
|
0 |
|a Endorphins
|x Receptors
|v Congresses.
|
650 |
|
0 |
|a Narcotics
|v Congresses.
|
650 |
|
6 |
|a Endorphines
|0 (CaQQLa)201-0006526
|v Congr�es.
|0 (CaQQLa)201-0378219
|
650 |
|
6 |
|a Endorphines
|0 (CaQQLa)201-0096803
|x Antagonistes
|0 (CaQQLa)201-0096803
|v Congr�es.
|0 (CaQQLa)201-0378219
|
650 |
|
6 |
|a Endorphines
|0 (CaQQLa)201-0060684
|x R�ecepteurs
|0 (CaQQLa)201-0060684
|v Congr�es.
|0 (CaQQLa)201-0378219
|
650 |
|
6 |
|a Drogues
|0 (CaQQLa)201-0005664
|v Congr�es.
|0 (CaQQLa)201-0378219
|
650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a Endorphin antagonists
|2 fast
|0 (OCoLC)fst00909801
|
650 |
|
7 |
|a Endorphins
|2 fast
|0 (OCoLC)fst00909802
|
650 |
|
7 |
|a Endorphins
|x Receptors
|2 fast
|0 (OCoLC)fst00909806
|
650 |
|
7 |
|a Narcotics
|2 fast
|0 (OCoLC)fst01032860
|
655 |
|
2 |
|a Congress
|0 (DNLM)D016423
|
655 |
|
7 |
|a proceedings (reports)
|2 aat
|0 (CStmoGRI)aatgf300027316
|
655 |
|
7 |
|a Conference papers and proceedings
|2 fast
|0 (OCoLC)fst01423772
|
655 |
|
7 |
|a Conference papers and proceedings.
|2 lcgft
|
655 |
|
7 |
|a Actes de congr�es.
|2 rvmgf
|0 (CaQQLa)RVMGF-000001049
|
700 |
1 |
|
|a Way, E. Leong.
|
776 |
0 |
8 |
|i Print version:
|t Endogenous and exogenous opiate agonists and antagonists.
|d Pergamon, 1980
|w (OCoLC)59064003
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780080254883
|z Texto completo
|
880 |
8 |
|
|6 505-00/(S
|a Chapter 4. THE SYNTHESIS AND AGONIST ACTIVITY OF SOME 14β-SUBSTITUTED MORPHINE AND CODEINE DERIVATIVESSynthesis; Acknowledgements; References; Chapter 5. 4-ARYL-4-AMINOCYCLOHEXANONE DERIVATIVES: A CHEMICALLY NOVEL SERIES OF ANALGESICS INCLUDING OPIOID ANTAGONISTS AND EXTREMELY POTENT AGONISTS.; Summary; Methods; Results and Discussion; References; Chapter 6. N-METHYLBENZOMORPHANALKANONES. A COMPARISON OF THEIR STRUCTURE-ACTIVITY RELATIONSHIPS AND X-RAY CRYSTAL STRUCTURE WITH THOSE OF THE BRIDGED THEBAINE DERIVATIVES. AN OPIATE RECEPTOR PROPOSAL; Summary; Acknowledgement; References.
|
880 |
0 |
|
|6 505-00/(S
|a Front Cover; Endogenous and Exogenous Opiate Agonists and Antagonists; Copyright Page; Table of Contents; Preface; WHO ROLE IN DRUG ADDICTION; REFERENCES; PART I: Structure-Activity Relationships; Chapter 1. PRIMARY STRUCTURE AND SPECIFICITY IN ENDOGENOUS OPIOID PEPTIDES; Summary; REFERENCES; Chapter 2. SYNTHETIC βh -ENDORPHIN ANALOGS MODIFIED AT THE N-TERMINAL, POSITIONS 2 AND 5; Summary; Methods; Results and Discussion; Acknowledgement; References; Chapter 3. CHEMICAL FEATURES FOR OPIATE AGONIST AND ANTAGONIST; Summary; Methods; Results and Discussion; References.
|
880 |
8 |
|
|6 505-01/(S
|a Chapter 7. QUANTUM CHEMICAL STUDIES OF NOVEL 4-PHENYL PIPERIDINE OPIATES WITH ANTAGONIST ACTIVITYSummary; Method and Procedure; Results and Discussion; Literature Cited; Acknowledgement; Chapter 8. STRUCTURE-FUNCTION STUDIES IN PEPTIDES RELATED TO THE β-LPH61-14 SEQUENCE; Summary; Methods; Results and Discussion; REFERENCES; Chapter 9. Enkephalin Analogs and Physical Dependence; Method of Drug Delivery; Measurement of Withdrawal Intensity; Discussion; Acknowledgments; References; PART II: Receptor Binding.
|